Nerve Injury

0
Pipeline Programs
2
Companies
3
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Epineuron
EpineuronON - Mississauga
2 programs
Temporary Peripheral Nerve Stimulation SystemN/A1 trial
Temporary Peripheral Nerve StimulatorN/A1 trial
Active Trials
NCT05721261RecruitingEst. Dec 2025
NCT04732936CompletedEst. Jun 2023
Medical Microinstruments
1 program
Symani® Surgical SystemN/A1 trial
Active Trials
NCT07084207RecruitingEst. Dec 2027

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
Medical MicroinstrumentsSymani® Surgical System
EpineuronTemporary Peripheral Nerve Stimulation System
EpineuronTemporary Peripheral Nerve Stimulator

Clinical Trials (3)

NCT07084207Medical MicroinstrumentsSymani® Surgical System

A Study to Expand the Use of Symani® Surgical System for Peripheral Nerve Repair

Start: Dec 2025Est. completion: Dec 2027
N/ARecruiting
NCT05721261EpineuronTemporary Peripheral Nerve Stimulation System

Regeneration of Acutely Injured Nerves With Temporary Electrical Stimulation

Start: Aug 2023Est. completion: Dec 2025
N/ARecruiting
NCT04732936EpineuronTemporary Peripheral Nerve Stimulator

Feasibility Study of a Temporary Peripheral Nerve Stimulator

Start: Apr 2021Est. completion: Jun 2023
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 actively recruiting trials
2 companies competing in this space